Paulina Maravilla-Herrera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Paulina Maravilla-Herrera has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Beatriz Gil
Roche Farma España, Madrid, Spain
1 shared publicationDaniel-Aníbal García-Diego
Federación Española de Hemofilia – FEDHEMO, Madrid, Spain
1 shared publicationElena Ruiz-Beato
Roche Farma España, Madrid, Spain
1 shared publicationInmaculada Soto
Hospital Universitario Central de Asturias, Oviedo, Spain
1 shared publicationJosÉ Mateo
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
1 shared publicationMaría Merino
Weber, Madrid, Spain
1 shared publication
Latest Publications
- Open Access
- 26 January 2022
- Published by Springer Nature in BMC Health Services Research
- Vol. 22 (1) , 1-10
The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis
Haemophilia A (HA) has been associated with poor health-related quality of life and a large economic burden, accentuated by severity, arthropathy, and inhibitors. To meet global standards of care, the management of HA should align with the principles of care outlined by the World Federation of Haemophilia. The aims of the present study were to establish a set of proposals to improve HA management within the Spanish National Health System (SNHS) and to estimate the impact its hypothetical implementation would generate from a clinical, healthcare, economic, and social perspective. A multidisciplinary group of experts agreed on a set of 15 proposals to improve HA management within the SNHS. Thereafter, a forecast-type Social Return on Investment analysis was carried out to estimate the impact of implementing this set of proposals within the SNHS over a one-year timeframe, in relation to the required investment. This study estimated that the implementation of the complete set of 15 proposals would require a total investment of 2.34 M€ and have a total impact of 14.60 M€. Accordingly, every euro invested in the complete set of 15 proposals would yield a social return of €6.23 (€3.37 in the worst-case scenario and €9.69 in the best-case scenario) of both tangible and intangible nature in similar proportions (45.71 and 54.29%, respectively). These results can be used to inform policy and practice such that interventions that may potentially improve current public health challenges associated with the management of HA may be implemented.
- 26 January 2022
- Published by Springer Nature in BMC Health Services Research
- Vol. 22 (1) , 1-10
Open AccessThe impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis
Haemophilia A (HA) has been associated with poor health-related quality of life and a large economic burden, accentuated by severity, arthropathy, and inhibitors. To meet global standards of care, the management of HA should align with the principles of care outlined by the World Federation of Haemophilia. The aims of the present study were to establish a set of proposals to improve HA management within the Spanish National Health System (SNHS) and to estimate the impact its hypothetical implementation would generate from a clinical, healthcare, economic, and social perspective. A multidisciplinary group of experts agreed on a set of 15 proposals to improve HA management within the SNHS. Thereafter, a forecast-type Social Return on Investment analysis was carried out to estimate the impact of implementing this set of proposals within the SNHS over a one-year timeframe, in relation to the required investment. This study estimated that the implementation of the complete set of 15 proposals would require a total investment of 2.34 M€ and have a total impact of 14.60 M€. Accordingly, every euro invested in the complete set of 15 proposals would yield a social return of €6.23 (€3.37 in the worst-case scenario and €9.69 in the best-case scenario) of both tangible and intangible nature in similar proportions (45.71 and 54.29%, respectively). These results can be used to inform policy and practice such that interventions that may potentially improve current public health challenges associated with the management of HA may be implemented.